News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
30-Mar-2004 - Leiden, The Netherlands. Dutch biotechnology company Crucell N.V. announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), will support the development of Crucell's candidate malaria vaccine. The agreement has an ...
26-Mar-2004 - Heidelberg. Scientists from European Molecular Biology Laboratory have identified four mosquito proteins that affect the ability of the malaria parasite (Plasmodium) to survive and develop in the malaria-carrier mosquito (Anopheles). This breakthrough, featured in recent issues of Cell and ...
25-Mar-2004 - Leiden, The Netherlands. Crucell N.V. and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, announced a new collaboration on the pre-clinical and clinical development of candidate tuberculosis (TB) vaccines. Aeras has agreed to provide Crucell up to USD$2.9 million contingent upon ...
16-Jan-2004 - Yale scientists have identified a mosquito smell receptor that specifically detects a chemical component of human sweat, a finding that may provide the basis for developing insect repellants for humans or for agricultural crops. Every year more than a million people worldwide die of malaria, a ...
14-Jan-2004 - SANTA CLARA, Calif. -- Affymetrix, Inc. today announced the launch of a Plasmodium/Anopheles Genome GeneChip(R) Array, the first commercial array that can be used to simultaneously study the entire expressed genomes of both the host mosquito, Anopheles gambiae, and the malaria parasite, ...
12-Dec-2003 - QIAGEN GmbH and artus GmbH announced that they have entered into a manufacturing and supply agreement. Pursuant to this agreement, artus will integrate QIAGEN's nucleic acid sample preparation products in its diagnostic systems for use in the detection of a variety of infectious diseases such as ...
17-Nov-2003 - Dutch biotechnology company Crucell N.V. presented encouraging study results on the efficacy of an experimental malaria vaccine at this week's Viral Vectors & Vaccines conference held in Las Vegas. The study is part of a close collaboration between Crucell and the Department of Medical and ...
Company Strengthens Leadership Position in Bt Insecticides
17-Mar-2003 - Valent BioSciences today announced it has acquired the worldwide public health business of Certis USA, including the Teknar(R) brands of insecticide products that control mosquito and black fly larvae. In addition, the company has licensed worldwide marketing rights for Thuricide(R) biological ...
09-Sep-2002 - London, September 5, 2002 -- GlaxoSmithKline (GSK) today announced that it has further reduced the not-for-profit preferential prices of its HIV/AIDS medicines by up to 33% and its anti-malarial medicines by up to 38%. The price reductions are the latest stage in GSK's efforts to improve ...
© 1997-2024 LUMITOS AG, All rights reserved